| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |